Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201103359 Principal Investigator: Waqar, Saiama
Title: An open label two-stage study of orally administered BKM120 in patients with metastatic non-small cell lung cancer with activated PI3K pathway
Phase: II Disease Site: Lung
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find out if the drug BKM120 is safe and has positive effects on patients with non-small cell lung cancer who have progressed after treatment.
 
More Information:
CT.gov link
Internal Protocol Documents (requires Siteman administrative database password)